Literature DB >> 10713673

RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.

S Zrihan-Licht1, Y Fu, J Settleman, K Schinkmann, L Shaw, I Keydar, S Avraham, H Avraham.   

Abstract

Focal adhesions and actin cytoskeleton are involved in cell growth, shape and movement and in tumor invasion. Mitogen-induced changes in actin cytoskeleton are accompanied by changes in the tyrosine phosphorylation of several focal adhesion proteins. In this study, we have investigated the role of RAFTK, a cytoplasmic tyrosine kinase related to focal adhesion kinase (FAK), in heregulin-mediated signal transduction in breast cancer cells. Stimulation of T47D cells with heregulin (HRG) induced the tyrosine phosphorylation of RAFTK and the formation of a multiprotein complex. Analyses of the members of the HRG-stimulated complex revealed that RAFTK is associated with p190 RhoGAP (p190), RasGAP and ErbB-2, and plays an essential role in mediating the tyrosine phosphorylation of p190 by Src. Mutation of the Src binding site within RAFTK (402) abolished the phosphorylation of p190. In addition, upon HRG stimulation of T47D cells, association of ErbB-2 with RAFTK was observed and found to be indirect and mediated by Src. Expression of wild-type RAFTK (WT) significantly increased MDA-MB-435 and MCF-7 breast cancer cell invasion, while expression of the kinase-mutated RAFTK-R457 (KM) or the Src binding site mutant RAFTK (402) did not affect this cell invasion. Furthermore, HRG leads to the activation of MAP kinase which is mediated by RAFTK. These findings indicate that RAFTK serves as a mediator and an integration point between the GAP proteins and HRG-mediated signaling in breast cancer cells, and implicate RAFTK involvement in the MAP kinase pathway and in breast cancer cell invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713673     DOI: 10.1038/sj.onc.1203422

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling.

Authors:  Alexandra Zanin-Zhorov; Liora Cahalon; Guy Tal; Raanan Margalit; Ofer Lider; Irun R Cohen
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

2.  PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.

Authors:  Terry W Moody; Alessia Di Florio; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2012-05-12       Impact factor: 3.444

3.  RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

Authors:  Megumi Iiizumi; Sucharita Bandyopadhyay; Sudha K Pai; Misako Watabe; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Ken Saito; Eiji Furuta; Wen Liu; Fei Xing; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  Pyk2 activation triggers epidermal growth factor receptor signaling and cell motility after wounding sheets of epithelial cells.

Authors:  Ethan R Block; Michael A Tolino; Jes K Klarlund
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity.

Authors:  W T Arthur; K Burridge
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

6.  TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer.

Authors:  M K Wendt; B J Schiemann; J G Parvani; Y-H Lee; Y Kang; W P Schiemann
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

7.  TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.

Authors:  Siyang Zhang; Dawei Guo; Wenting Luo; Qingfu Zhang; Ying Zhang; Chunyan Li; Yao Lu; Zeshi Cui; Xueshan Qiu
Journal:  BMC Cancer       Date:  2010-02-16       Impact factor: 4.430

8.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

9.  Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression.

Authors:  Uri Sela; Sharon Ganor; Iris Hecht; Alexander Brill; Talia Miron; Aharon Rabinkov; Meir Wilchek; David Mirelman; Ofer Lider; Rami Hershkoviz
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

10.  Non-receptor-tyrosine kinases integrate fast glucocorticoid signaling in hippocampal neurons.

Authors:  Silei Yang; Francesco Roselli; Alexandre V Patchev; Shuang Yu; Osborne F X Almeida
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.